Form 8-K · Item 4.01 · Auditor change
Stoke Therapeutics, Inc.: auditor change, KPMG LLP to Ernst & Young LLP
Stoke Therapeutics, Inc. reported in a Form 8-K filed March 27, 2026, that on March 23, 2026, KPMG LLP was dismissed as its certifying accountant, and Ernst & Young LLP was engaged. The filing reports no disagreements with the former accountant.
In the filing's words
On March 23, 2026, the Audit Committee (the “Audit Committee”) of the Board of Directors of Stoke Therapeutics, Inc. (the “Company”) dismissed KPMG LLP (“KPMG”) as the Company’s independent registered public accounting firm.
there were (i) no disagreements within the meaning of Item 304(a)(1)(iv) of Regulation S-K between the Company and KPMG on any matter of accounting principles or practices, financial statement disclosure, or auditing scope or procedure
On March 23, 2026, the Audit Committee approved the engagement of Ernst & Young LLP (“EY”) as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
Verbatim from sec.gov, Item 4.01 (Changes in Registrant's Certifying Accountant). We quote the filing; we do not characterize it.
| Company | Stoke Therapeutics, Inc. |
|---|---|
| Ticker | STOK |
| Form and item | 8-K, Item 4.01 |
| Filed with the SEC | March 27, 2026 |
| What the filing states | dismissed, engaged |
| Former accountant | KPMG LLP |
| New accountant | Ernst & Young LLP |
| Date of the change | March 23, 2026 |
| Disagreements | none reported |
| Auditor's letter | Exhibit 16 on sec.gov |
| Accession number | 0001193125-26-129168 |
| SEC CIK | 0001623526 |
Stoke Therapeutics, Inc. reported under Form 8-K Item 4.01 (Changes in Registrant's Certifying Accountant), filed March 27, 2026. The filing's own words are quoted above.
Sources
More: all auditor changes · Something wrong? Send a correction with the primary source.